Globally malnutrition is associated with 50% of all deaths amongst children. Recurrent bouts of diarrhoea, caused by poor hygiene and sanitation, causes damage to the lining of the child's stomach disrupting their ability to digest and absorb whole proteins.
The resulting chronic protein energy malnutrition lowers children's resistance to infection and disease resulting in high global child mortality rates.
Medicine Mondiale has developed a novel nutritional ingredient called Amino Natural which is made from whole proteins that have been hydrolysed using natural Kiwifruit enzymes, to produce a mixture of amino acids and co-peptides.
These molecules are so small they can be absorbed without the need for digestion and are rapidly incorporated into muscle tissue.
The natural immunogenic peptides in Amino Natural also help to repair the damage to the child's stomach lining and because Amino Natural is very high in branched chain amino acids, this means more protein may be absorbed from other local dietary foods.
In 2017 Medicine Mondiale will launch Amigo Bars throughout the Pacific Region.
Amigo Bars are ready to eat, meal replacement Bars containing Amino Natural specifically designed to provide all the essential nutritional requirements for healthy development of children.
Each year eight million children die before their 5th birthday. Three million of these deaths occur in the first 28 days and there is nothing more saddening than to watch helplessly as a new born babies' life ends. It doesn't have to be this way. Many of these deaths are preventable if babies are placed in the safety and warmth of a neonatal incubator.
Current high tech lifesaving incubators are expensive and are not designed to work in the challenging hospitals of the developing world. The average lifespan of an infant incubator in a hospital in Africa is less than eighteen months.
The Mondiale LifePod incubator is designed to be indestructible, purifies its own air and water, costs only $2,000 and will run continuously without the need for replacement parts or maintenance by trained technicians.
Using lean design and manufacturing principles, as well as state of the art materials, the LifePod incubator is lifecycle tested to 100,000 hours of continuous running and the Patented Mondiale humidification system prevents the propagation of pathogenic bacteria within the incubator.
Join us in our endeavour to bring this life changing incubator to the world, donate specifically to a LifePod here.
The administration of medicines and rehydration fluids by Intravenous Infusion (IV) is the most common medical procedure employed worldwide. In first world hospitals, microprocessor controlled syringe pumps, costing $US2,000 plus, are used to ensure accurate and safe drug delivery. However, in the developing world, a 50 cent plastic roller clamp is used to control IV flow rates for the administration of highly potent medicines.
Even a 3mm movement of the roller clamp may be the difference between life and death and it is almost impossible to accurately control low IV infusion rates required to safely treat children. In addition, nursing staff have to constantly readjust the roller clamp to maintain the correct infusion rate and in crisis situations, patients are often left to treat themselves with fatal results.
Medicine Mondiale has developed the Acuset IV Flow Controller, a reusable IV Flow Controller which is intuitive to use even by relatively untrained operators and eliminates the clinical errors associated with the use of the traditional roller clamp IV flow controller.
The patented Dial-a-Flow mechanism allows flow rates to be accurately set and maintained with a high degree of accuracy and precision, improving patient safety and making every dollar spent on healthcare stretch further.
The Medicine Mondiale Acuset IV Flow Controller clips to the outside of the IV set and therefore is reusable. The Acuset has the potential to save millions of lives and improve the quality of clinical care throughout the developing world.
The Acuset IV Flow Controller offers..
To find out more about Acuset or to purchase, contact email@example.com
Despite the well meaning efforts of Governments, international NGOs and the disbursement of billions of dollars of aid, primary healthcare in the developing world setting has not improved significantly in the past twenty years.
Independent assessments show that there is a large gap between public statements made by NGOs and what is realized in practice.
Most critically, many development initiatives are "action" driven rather than quality driven which results in poor, non clinically proven, products and practices being applied which is wasteful and often results in poor healthcare outcomes.
By way of example, during the 1970's Unicef sponsored a program for drilling tube wells in Bangladesh to provide "safe" drinking water for the population.
Today more than 30 million people in Bangladesh are drinking water contaminated with arsenic because Unicef did not test the well water for toxic arsenic contamination.
The Unicef tube well program in Bangladesh has been described as the biggest mass poisoning in history.
Today Unicef continues to sponsor the drilling of wells on a global scale but has no documented procedures in place for testing the wells for bacteriological or chemical contamination to ensure that these wells produce water that is safe to drink.
Non Governmental Organizations are mostly self regulated and often deploy products and services which are not subject to the same scientific rigor and mandatory regulatory requirements required in the developed world.
Medicine Mondiale has established the Ethical Science Group and independent panel of experts and student volunteers who conduct Quality Analysis of Global Healthcare Initiatives to determine the effectiveness and efficiency of healthcare initiatives deployed in the developing world setting.
This comprises reviewing the quality and reliability of clinical trial data used to support (validate) global healthcare initiatives including meta statistical analysis of current research archives and Failure Mode Effect Analysis (FMEA Risk analysis) of global healthcare strategies.
The aim of the Ethical Science Group is to improve the quality and efficacy of healthcare throughout the developing world and our research results will be published in Medical Journals and distributed to NGOs and the International media.
If you are interested in contributing to the Medicine Mondiale Ethical Science Group, please contact us.